Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $66.7 million.

  • Rhythm Pharmaceuticals' Shares Outstanding rose 854.19% to $66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.7 million, marking a year-over-year increase of 854.19%. This contributed to the annual value of $62.4 million for FY2024, which is 498.78% up from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Shares Outstanding stood at $66.7 million, which was up 854.19% from $63.9 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' Shares Outstanding's 5-year high stood at $66.7 million during Q3 2025, with a 5-year trough of $50.2 million in Q1 2021.
  • Over the past 5 years, Rhythm Pharmaceuticals' median Shares Outstanding value was $56.9 million (recorded in 2023), while the average stood at $57.2 million.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Shares Outstanding skyrocketed by 1386.62% in 2021 and then soared by 38.24% in 2022.
  • Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Shares Outstanding stood at $50.3 million in 2021, then increased by 12.59% to $56.6 million in 2022, then rose by 4.97% to $59.4 million in 2023, then grew by 4.99% to $62.4 million in 2024, then increased by 6.88% to $66.7 million in 2025.
  • Its Shares Outstanding stands at $66.7 million for Q3 2025, versus $63.9 million for Q2 2025 and $63.5 million for Q1 2025.